Cargando…

Influence of country-level differences on COPD prevalence

PURPOSE: Studies suggest that COPD prevalence may vary between countries. We conducted an ecological study of data from COPD prevalence articles to assess the influence of differences in country-level risk factors on COPD prevalence. PATIENTS AND METHODS: Our study covered English language articles...

Descripción completa

Detalles Bibliográficos
Autores principales: Aaron, Shawn D, Gershon, Andrea S, Gao, Yuan, Yang, Jenna, Whitmore, GA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034923/
https://www.ncbi.nlm.nih.gov/pubmed/27698561
http://dx.doi.org/10.2147/COPD.S113868
_version_ 1782455350609313792
author Aaron, Shawn D
Gershon, Andrea S
Gao, Yuan
Yang, Jenna
Whitmore, GA
author_facet Aaron, Shawn D
Gershon, Andrea S
Gao, Yuan
Yang, Jenna
Whitmore, GA
author_sort Aaron, Shawn D
collection PubMed
description PURPOSE: Studies suggest that COPD prevalence may vary between countries. We conducted an ecological study of data from COPD prevalence articles to assess the influence of differences in country-level risk factors on COPD prevalence. PATIENTS AND METHODS: Our study covered English language articles published during 2003–2014. Qualified articles used spirometry to assess COPD prevalence and used representative samples from national or subnational populations. Stepwise binomial regression was used to analyze associations between study- and country-level factors and COPD prevalence. RESULTS: Eighty articles provided 1,583 measures of COPD prevalence for subjects in different sex, age, and smoking categories for 112 districts in 41 countries. Adjusted prevalence rates for COPD were significantly lower for Australia/New Zealand and the Mediterranean and significantly higher for Latin America, compared to North America, Southeast Asia, and Northern Europe. Country-level socioeconomic development variables had an uneven and mixed association with COPD prevalence. High elevation above sea level was shown to be a protective factor for COPD. Study-level variables for the established risk factors of sex, age, and smoking explained 64% of variability in COPD prevalence. Country-level risk factors raised the explanatory power to 72%. Approximately 28% of worldwide variability in COPD prevalence remained unexplained. CONCLUSION: Our study suggests that COPD prevalence varies across world regions, even after adjustment for established risk factors. Major country-level risk factors contributing to the worldwide epidemic of COPD remain to be investigated.
format Online
Article
Text
id pubmed-5034923
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-50349232016-10-03 Influence of country-level differences on COPD prevalence Aaron, Shawn D Gershon, Andrea S Gao, Yuan Yang, Jenna Whitmore, GA Int J Chron Obstruct Pulmon Dis Original Research PURPOSE: Studies suggest that COPD prevalence may vary between countries. We conducted an ecological study of data from COPD prevalence articles to assess the influence of differences in country-level risk factors on COPD prevalence. PATIENTS AND METHODS: Our study covered English language articles published during 2003–2014. Qualified articles used spirometry to assess COPD prevalence and used representative samples from national or subnational populations. Stepwise binomial regression was used to analyze associations between study- and country-level factors and COPD prevalence. RESULTS: Eighty articles provided 1,583 measures of COPD prevalence for subjects in different sex, age, and smoking categories for 112 districts in 41 countries. Adjusted prevalence rates for COPD were significantly lower for Australia/New Zealand and the Mediterranean and significantly higher for Latin America, compared to North America, Southeast Asia, and Northern Europe. Country-level socioeconomic development variables had an uneven and mixed association with COPD prevalence. High elevation above sea level was shown to be a protective factor for COPD. Study-level variables for the established risk factors of sex, age, and smoking explained 64% of variability in COPD prevalence. Country-level risk factors raised the explanatory power to 72%. Approximately 28% of worldwide variability in COPD prevalence remained unexplained. CONCLUSION: Our study suggests that COPD prevalence varies across world regions, even after adjustment for established risk factors. Major country-level risk factors contributing to the worldwide epidemic of COPD remain to be investigated. Dove Medical Press 2016-09-19 /pmc/articles/PMC5034923/ /pubmed/27698561 http://dx.doi.org/10.2147/COPD.S113868 Text en © 2016 Aaron et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Aaron, Shawn D
Gershon, Andrea S
Gao, Yuan
Yang, Jenna
Whitmore, GA
Influence of country-level differences on COPD prevalence
title Influence of country-level differences on COPD prevalence
title_full Influence of country-level differences on COPD prevalence
title_fullStr Influence of country-level differences on COPD prevalence
title_full_unstemmed Influence of country-level differences on COPD prevalence
title_short Influence of country-level differences on COPD prevalence
title_sort influence of country-level differences on copd prevalence
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034923/
https://www.ncbi.nlm.nih.gov/pubmed/27698561
http://dx.doi.org/10.2147/COPD.S113868
work_keys_str_mv AT aaronshawnd influenceofcountryleveldifferencesoncopdprevalence
AT gershonandreas influenceofcountryleveldifferencesoncopdprevalence
AT gaoyuan influenceofcountryleveldifferencesoncopdprevalence
AT yangjenna influenceofcountryleveldifferencesoncopdprevalence
AT whitmorega influenceofcountryleveldifferencesoncopdprevalence